Physician profile
Harry Marshak
NPI 1174560825
$1,399.29
in general payments reported to CMS, 2019-2025
8 companies · $166 in 2025
The $166 reported for 2025 was less than what a typical Ophthalmic Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $299).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $372 · 2020: $17.01 · 2021: $245 · 2022: $18.28 · 2023: $395 · 2024: $186 · 2025: $166.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $747.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $747.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $683.98 | 2023-2025 | |
| Horizon Therapeutics Plc | $206.93 | 2019-2021 | |
| Allergan, INC. | $205.97 | 2019-2021 | |
| Biotissue Holdings INC. | $103.70 | 2019 | |
| Alcon Vision LLC | $99.88 | 2019 | |
| Boston Scientific Corporation | $35.52 | 2025 | Wavewriter Alpha Prime 16 |
| Galderma Laboratories, L.P. | $35.35 | 2021-2022 | |
| Merz North America, INC. | $27.96 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harry Marshak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.